Navigation Links
Cannabinoids drug for inflammatory bowel

Researchers from the University of Bath, UK has found that Cannabinoids derived from Cannabis has found to be effective in the treatment of inflammatory bowel diseases like Crohn’s disease and //ulcerative colitis. "The system that responds to cannabis in the brain is present and functioning in the lining of the gut," lead researcher Dr. Karen Wright, of the University of Bath, explained to Reuters Health. "There is an increased presence of one component of this system during inflammatory bowel diseases," she explained.

The report of the study was published in the Journal of Gastroenterology in which she has explained the location of CB1 and CB2 receptors in human colon tissue which binds to the Cannabinoid. She has used Human colon cell lines to establish the binding of the cannabinoid compounds and in her wound healing experiments.

Increased CB2 receptors are found in colonic tissue characteristic of inflammatory bowel disease. They found that the Cannabinoids helps in wound healing of the surface by CB1 related receptor mechanism.

"Cannabinoids, which we make ourselves, as well as synthetic Cannabinoids, can promote wound healing in the gut, which is extremely interesting given that inflammatory bowel disease involves damaged gut linings," Wright said.

(SOURCE: The Journal of Gastroenterology)

'"/>




Page: 1

Related medicine news :

1. Cannabinoids - Antidepressant And Inflammatory Bowel Disease Treatment
2. Safeguarding anti-inflammatory users from ulcers
3. Gel pares inflammatory activity throughout body
4. Anti-inflammatory drugs reduce the risk of oral cancer for smokers
5. Leptin and inflammatory cytokines in women with pre-eclampsia
6. Protein Secreted By Worm Eggs Holds Key To Anti-inflammatory Therapy
7. Nonsteroidal anti-inflammatory drugs could cause gastrointestinal complications.
8. Anti-inflammatory Drug Fails to Improve COPD Symptoms
9. A rare complication of bowel disease
10. Shelved bowel-syndrome drug still in demand
11. Novel test for bowel cancer
Post Your Comments:
Breaking Medicine Technology:Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 2Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 3Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 4Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 5Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 6Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 7Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 8Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 9Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 10Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 11Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 12Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 13Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 14Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 15Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 16Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 17Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 18Cubist Pharmaceuticals Becomes First Company to Implement Integrated Reprints Desk Document Delivery and QUOSA Scientific Literature Workflow Solution 2Cubist Pharmaceuticals Becomes First Company to Implement Integrated Reprints Desk Document Delivery and QUOSA Scientific Literature Workflow Solution 3Heska Announces Extension of Credit Agreement With Wells Fargo 2Heska Announces Extension of Credit Agreement With Wells Fargo 3Study Shows That Diets of Infants are Improving 3B Concerns Remain for Toddlers and Preschoolers 59710 1Study Shows That Diets of Infants are Improving 3B Concerns Remain for Toddlers and Preschoolers 59710 2Study Shows That Diets of Infants are Improving 3B Concerns Remain for Toddlers and Preschoolers 59710 3Study Shows That Diets of Infants are Improving 3B Concerns Remain for Toddlers and Preschoolers 59710 4Study Shows That Diets of Infants are Improving 3B Concerns Remain for Toddlers and Preschoolers 59710 5Study Shows That Diets of Infants are Improving 3B Concerns Remain for Toddlers and Preschoolers 59710 6Study Shows That Diets of Infants are Improving 3B Concerns Remain for Toddlers and Preschoolers 59710 7Fate Therapeutics Announces Creation of Small Molecule Platform for Commercial Scale Reprogramming 14517 1Fate Therapeutics Announces Creation of Small Molecule Platform for Commercial Scale Reprogramming 14517 2Fate Therapeutics Announces Creation of Small Molecule Platform for Commercial Scale Reprogramming 14517 3New chromosomal abnormality identified in leukemia associated with Down syndrome 10408 1New chromosomal abnormality identified in leukemia associated with Down syndrome 10408 2New chromosomal abnormality identified in leukemia associated with Down syndrome 10408 3